$CBT

A live call on Cabot's fourth-quarter results starts at 8 a.m. ET Nov. 3

Cabot Corporation (NYSE: CBT) will release its Q4 2026 results on Nov. 2 after market close and host a conference call on Nov. 3 at 8 a.m. ET. The call will be webcast and archived on the company's website. Cabot is a global specialty chemicals and performance materials company.

Original reporting
Published Oct 13, 2026, 8:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CBT
Neutral
medium confidence
Mentioned
$CBT
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CBTNeutralLow
01

Why it matters

The timing announcement may generate modest trading volume as investors position for the upcoming results.

02

Market read

The article provides the first public notice of Cabot's Q4 2026 earnings release date, offering a small trading hook.

03

What to watch

Potential impact of macro‑economic trends on Cabot's battery material demand could be under‑appreciated.

Relevance 5/10Novelty 4/10Timing: pre‑market on Nov 3, 2026

Background

Cabot Corp is a global specialty chemicals company; earnings releases often move its stock.

Company-level read

Ticker impact

$CBTNeutralMedium confidence
Context

Cabot Corp announced its Q4 2026 operating results will be released after market close on Nov 2, with a live earnings call on Nov 3.

Expected impact

potential pressure as traders price in the upcoming earnings and guidance

Evidence & confidence

No new financial numbers are disclosed; the news is a schedule announcement that may cause modest pre‑earnings positioning.

Market effects

Signals upcoming data for the specialty chemicals sector; peers may see modest volatility ahead of Cabot's results.

Limited to U.S. investors tracking earnings season; no broader regional effect.

Low global relevance; primarily of interest to analysts covering industrial chemicals.

Counterpoint

If the market expects a beat, the lack of guidance may lead to a sell‑off on disappointment.

Key entities

  • Cabot Corporation

    Global specialty chemicals and performance materials producer.

Related articles

$CBTMed

Can Cabot (CBT) Justify Its Valuation On A $50 Million DOE Grant?

Cabot (CBT) secured a $50M DOE grant to expand its battery materials platform. Shares are at $78.80, down 15.35% over 90 days but up 17.52% YTD. The company has a strong balance sheet and has returned $73M to shareholders recently. Analysts debate if the stock is undervalued at $78.80 vs. a fair value of $88.50.

$CBTMed

Cabot Details Interim CFO Appointment as CEO Succession Nears

Cabot Corporation (NYSE: CBT) appointed Steve Delahunt as interim CFO effective 1 October 2026. This follows CEO Sean Keohane's retirement and CFO Erica McLaughlin's promotion to president and CEO. The company reported a significant drop in Q3 2026 net income to $6M from $101M year-over-year, while revenue rose to $982M from $923M. CBT shares were at $80.73 as of 15 September, up 3.18% in 24 hours but down 3.39% over 20 days.

$CBTMedAI 8/10

What Cabot (CBT)'s New 2029 Debt Issuance and 2026 Note Redemption Means For Shareholders

Cabot Corporation (CBT) issued $350M in 4.950% senior notes due 2029, using proceeds to redeem $250M in 3.40% notes maturing in September 2026 and for working capital. The company projects $4B revenue and $479.7M earnings by 2029, requiring 3.5% yearly revenue growth. Analysts' views vary on earnings potential, with some estimating $499M by 2029. The refinancing aims to improve financial flexibility but does not alter near-term business challenges, including margin stabilization and Reinforcemen

$CBTMedAI 8/10

Cabot’s New US$350 Million Bond Issue Might Change The Case For Investing In CBT

Cabot Corporation issued US$350 million in senior unsecured notes due 2029, altering its funding mix. The move may impact investor views on balance sheet flexibility, especially as earnings have softened. Q3 2026 results showed US$6 million net income on US$982 million sales, with full-year EPS guidance of US$2.77. The company projects US$4.0 billion revenue and US$479.7 million earnings by 2029.